Inhibition of B-cell lymphoma type 2 (BCL-2) and related proteins

MA43871AUndetermined Publication Date: 2018-11-21MERRIMACK PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA43871
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-01-09
Filing Date
2017-01-11
Publication Date
2018-11-21
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.